Phase II conjugates of urolithins isolated from human urine and potential role of β-glucuronidases in their disposition

Drug Metabolism and Disposition

Volumn 45, Issue 6, 2017, Pages 657-665

  Piwowarski, Jakub P ^a   Stanisławska, Iwona ^a   Granica, Sebastian ^a   Stefanska, Joanna ^a   Kiss, Anna K ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; ISO UROLITHIN A; NATURAL PRODUCT; UNCLASSIFIED DRUG; UROLITHIN A; UROLITHIN B; 3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; BIOLOGICAL PRODUCT; COUMARIN DERIVATIVE; TANNIN;

ADULT; ARTICLE; BACTERIAL STRAIN; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ISOLATION; CONCENTRATION RESPONSE; DRUG DISPOSITION; ESCHERICHIA COLI; HUMAN; HUMAN EXPERIMENT; MALE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINE; CHEMISTRY; METABOLISM; PLASMA; URINARY TRACT INFECTION;

ADULT; BIOLOGICAL PRODUCTS; COUMARINS; GLUCURONIDASE; HUMANS; HYDROLYZABLE TANNINS; MALE; PLASMA; URINARY TRACT INFECTIONS; URINE;

EID: 85019259090     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.117.075200     Document Type: Article

References (48)

1. Adams LS, Zhang Y, Seeram NP, Heber D, and Chen S (2010) Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila) 3:108-113.
2. Chang GW, Brill J, and Lum R (1989) Proportion of beta-D-glucuronidase-negative Escherichia coli in human fecal samples. Appl Environ Microbiol 55:335-339.
3. Dellafiora L, Mena P, Cozzini P, Brighenti F, and Del Rio D (2013) Modelling the possible bioactivity of ellagitannin-derived metabolites. In silico tools to evaluate their potential xenoestrogenic behavior. Food Funct 4:1442-1451.
4. Espín JC, Larrosa M, García-Conesa MT, and Tomás-Barberán F (2013) Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med 2013:270418.
5. García-Villalba R, Espín JC, and Tomás-Barberán FA (2016) Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid. J Chromatogr A 1428:162-175.
6. Giménez-Bastida JA, González-Sarrías A, Larrosa M, Tomás-Barberán F, Espín JC, and García-Conesa MT (2012) Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-a-induced inflammation and associated molecular markers in human aortic endothelial cells. Mol Nutr Food Res 56:784-796.
7. González-Barrio R, Borges G, Mullen W, and Crozier A (2010) Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J Agric Food Chem 58:3933-3939.
8. González-Barrio R, Truchado P, Ito H, Espín JC, and Tomás-Barberán FA (2011) UV and MS identification of Urolithins and Nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals. J Agric Food Chem 59:1152-1162.
9. González-Sarrías A, Espín JC, Tomás-Barberán FA, and García-Conesa MT (2009) Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res 53:686-698.
10. González-Sarrías A, Giménez-Bastida JA, García-Conesa MT, Gómez-Sánchez MB, García-Talavera NV, Gil-Izquierdo A, Sánchez-Alvarez C, Fontana-Compiano LO, Morga-Egea JP, Pastor-Quirante FA, et al. (2010) Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol Nutr Food Res 54:311-322.
11. González-Sarrías A, Giménez-Bastida JA, Núñez-Sánchez MA, Larrosa M, García-Conesa MT, Tomás-Barberán FA, and Espín JC (2014) Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells. Eur J Nutr 53:853-864.
12. González-Sarrías A, Miguel V, Merino G, Lucas R, Morales JC, Tomás-Barberán F, Alvarez AI, and Espín JC (2013) The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP). J Agric Food Chem 61:4352-4359.
13. González-Sarrías A, Núñez-Sánchez MÁ, García-Villalba R, Tomás-Barberán FA, and Espín JC (2017) Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism. Eur J Nutr 56:831-841.
14. González-Sarrías A, Núñez-Sánchez MA, Tomé-Carneiro J, Tomás-Barberán FA, García-Conesa MT, and Espín JC (2016) Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: MicroRNA cell specific induction of CDKN1A (p21) as a common mechanism involved. Mol Nutr Food Res 60:701-716.
15. Helander A and Dahl H (2005) Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption. Clin Chem 51:1728-1730.
16. Ho KJ (1985) Human beta-glucuronidase. Studies on the effects of pH and bile acids in regard to its role in the pathogenesis of cholelithiasis. Biochim Biophys Acta 827:197-206.
17. Ishisaka A, Kawabata K, Miki S, Shiba Y, Minekawa S, Nishikawa T, Mukai R, Terao J, and Kawai Y (2013) Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS One 8: e80843.
18. Kawai Y (2014) b-Glucuronidase activity and mitochondrial dysfunction: the sites where flavonoid glucuronides act as anti-inflammatory agents. J Clin Biochem Nutr 54:145-150.
19. Kieran T and Del Rio D (2015) Diet-Microbe Interactions in the Gut. Effects on human health and disease, Academic Press, London.
20. Klaassen CD and Cui JY (2015) Review: mechanisms of how the intestinal microbiota alters the effects of drugs and bile acids. Drug Metab Dispos 43:1505-1521.
21. Larrosa M, García-Conesa MT, Espín JC, and Tomás-Barberán FA (2010a) Ellagitannins, ellagic acid and vascular health. Mol Aspects Med 31:513-539.
22. Larrosa M, González-Sarrías A, García-Conesa MT, Tomás-Barberán FA, and Espín JC (2006) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54:1611-1620.
23. Larrosa M, González-Sarrías A, Yáñez-Gascón MJ, Selma MV, Azorín-Ortuño M, Toti S, Tomás-Barberán F, Dolara P, and Espín JC (2010b) Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem 21:717-725.
24. Lucas R, Alcantara D, and Morales JC (2009) A concise synthesis of glucuronide metabolites of urolithin-B, resveratrol, and hydroxytyrosol. Carbohydr Res 344:1340-1346.
25. McLellan LK and Hunstad DA (2016) Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med 22:946-957.
26. Mora-Cubillos X, Tulipani S, Garcia-Aloy M, Bulló M, Tinahones FJ, and Andres-Lacueva C (2015) Plasma metabolomic biomarkers of mixed nuts exposure inversely correlate with severity of metabolic syndrome. Mol Nutr Food Res 59:2480-2490.
27. Nuñez-Sánchez MA, García-Villalba R, Monedero-Saiz T, García-Talavera NV, Gómez-Sánchez MB, Sánchez-Álvarez C, García-Albert AM, Rodríguez-Gil FJ, Ruiz-Marín M, Pastor-Quirante FA, et al. (2014) Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol Nutr Food Res 58:1199-1211.
28. Palsson-McDermott EM and O'Neill LA (2013) The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays 35:965-973.
29. Pearson AG, Kiefel MJ, Ferro V, and von Itzstein M (2005) Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid. Carbohydr Res 340:2077-2085.
30. Piwowarski JP, Granica S, and Kiss AK (2014a) Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils. Planta Med 80:887-895.
31. Piwowarski JP, Granica S, Stefanska J, and Kiss AK (2016) Differences in metabolism of ellagitannins by human gut microbiota ex vivo cultures. J Nat Prod 79:3022-3030.
32. Piwowarski JP, Granica S, Zwierzyhska M, Stefahska J, Schopohl P, Melzig MF, and Kiss AK (2014b) Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials. J Ethnopharmacol 155:801-809.
33. Piwowarski JP and Kiss AK (2013) C-glucosidic ellagitannins from Lythri herba (European Pharmacopoeia): chromatographic profile and structure determination. Phytochem Anal 24:336-348.
34. Piwowarski JP, Kiss AK, Granica S, and Moeslinger T (2015) Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages. Mol Nutr Food Res 59:2168-2177.
35. Ryu D, Mouchiroud L, Andreux PA, Katsyuba E, Moullan N, Nicolet-Dit-Félix AA, Williams EG, Jha P, Lo Sasso G, Huzard D, et al. (2016) Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med 22:879-888.
36. Sala R, Mena P, Savi M, Brighenti F, Crozier A, Miragoli M, Stilli D, and Del Rio D (2015) Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions. J Funct Foods 15:97-105.
37. Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, Harris DM, Rettig M, Suchard MA, et al. (2007) Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 55:7732-7737.
38. Shimoi K, Saka N, Nozawa R, Sato M, Amano I, Nakayama T, and Kinae N (2001) Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab Dispos 29:1521-1524.
39. Siegers C, Bodinet C, Ali SS, and Siegers CP (2003) Bacterial deconjugation of arbutin by Escherichia coli. Phytomedicine 10(Suppl 4):58-60.
40. Sun N, Youle RJ, and Finkel T (2016) The Mitochondrial Basis of Aging. Mol Cell 61:654-666.
41. Tomás-Barberán FA, García-Villalba R, González-Sarrías A, Selma MV, and Espín JC (2014) Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J Agric Food Chem 62:6535-6538.
42. Tomás-Barberán FA, González-Sarrías A, García-Villalba R, Núñez-Sánchez MA, Selma MV, García-Conesa MT, and Espín JC (2017) Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol Nutr Food Res 61.
43. Tranoy-Opalinski I, Legigan T, Barat R, Clarhaut J, Thomas M, Renoux B, and Papot S (2014) β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update. Eur J Med Chem 74:302-313.
44. van der Hooft JJ, de Vos RC, Mihaleva V, Bino RJ, Ridder L, de Roo N, Jacobs DM, van Duynhoven JP, and Vervoort J (2012) Structural elucidation and quantification of phenolic conjugates present in human urine after tea intake. Anal Chem 84:7263-7271.
45. Vinacur JC, Casellas JM, Rubi RA, and Oneto EP (1974) Serum anti-Escherichia coli antibodies and urinary beta-glucuronidase for the diagnosis and control of evolution of urinary infection during pregnancy. Am J Obstet Gynecol 120:812-816.
46. Warburg O (1956a) On respiratory impairment in cancer cells. Science 124:269-270.
47. Warburg O (1956b) On the origin of cancer cells. Science 123:309-314.
48. Yip LY and Chan EC (2015) Investigation of host-gut microbiota modulation of therapeutic outcome. Drug Metab Dispos 43:1619-1631.